Cargando…
Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning
Ischemic heart disease is a significant public health problem with high mortality and morbidity. Extensive scientific investigations from basic sciences to clinics revealed multilevel alterations from metabolic imbalance, altered electrophysiology, and defective Ca(2+)/Na(+) homeostasis leading to l...
Autores principales: | Rouhana, Sarah, Virsolvy, Anne, Fares, Nassim, Richard, Sylvain, Thireau, Jérôme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777683/ https://www.ncbi.nlm.nih.gov/pubmed/35056088 http://dx.doi.org/10.3390/ph15010031 |
Ejemplares similares
-
Emerging clinical role of ranolazine in the management of angina
por: Vadnais, David S, et al.
Publicado: (2010) -
Antagonism of Na(v) channels and α(1)-adrenergic receptors contributes to vascular smooth muscle effects of ranolazine
por: Virsolvy, Anne, et al.
Publicado: (2015) -
Renal phospholipidosis possibly induced by ranolazine
por: Scheurle, Christoph, et al.
Publicado: (2014) -
COVID-19-related arrhythmias and the possible effects of ranolazine
por: Chukwunyere, Ugochukwu, et al.
Publicado: (2021) -
Possible Interaction between Dabigatran and Ranolazine in Patients with Renal Failure
por: Gumbrevičius, Gintautas, et al.
Publicado: (2019)